These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 408988

  • 1. [Follicular mucinosis with generalized para-amyloidosis as a cutaneous paraneoplastic syndrome in myeloma (IgD and light chain plasmacytoma). A demonstration of the course using melphalan-prednisone therapy with a 3 years remission].
    Jänner M, Lippert HD, Stolzenbach G.
    Z Hautkr; 1977 Aug 15; 52(16):873-40. PubMed ID: 408988
    [No Abstract] [Full Text] [Related]

  • 2. [Follicular mucinosis and large area, partly lichenoid, partly sclerodermiform generalized paramyloidosis as a cutaneous paraneoplastic syndrome in myeloma (IgD and light chain plasmacytoma)].
    Jänner M, Lippert HD, Stolzenbach G.
    Z Hautkr; 1974 Aug 15; 49(16):673-81. PubMed ID: 4278795
    [No Abstract] [Full Text] [Related]

  • 3. [Amyloidosis in a mixed pattern. Sensitivity to colchicine and melphalan].
    Frustaci A, Gentiloni N, Feoli F.
    Minerva Med; 1981 Apr 14; 72(15):957-60. PubMed ID: 6784038
    [Abstract] [Full Text] [Related]

  • 4. Regression of amyloidosis in multiple myeloma.
    Mehta AD.
    Br J Clin Pract; 1978 Dec 14; 32(12):358-9, 61. PubMed ID: 737115
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A patient with multiple myeloma, amyloidosis and light-chain deposition disease in kidneys with a long survival.
    Christou L, Hatzimichael EC, Sotsiou-Candila F, Siamopoulos K, Bourantas KL.
    Acta Haematol; 1999 Dec 14; 101(4):202-5. PubMed ID: 10436302
    [Abstract] [Full Text] [Related]

  • 7. Primary systemic amyloidosis with delayed progression to multiple myeloma.
    Rajkumar SV, Gertz MA, Kyle RA.
    Cancer; 1998 Apr 15; 82(8):1501-5. PubMed ID: 9554527
    [Abstract] [Full Text] [Related]

  • 8. Remission maintenance therapy for multiple myeloma.
    Arch Intern Med; 1975 Jan 15; 135(1):147-52. PubMed ID: 1111463
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine.
    Kyle RA, Gertz MA, Greipp PR, Witzig TE, Lust JA, Lacy MQ, Therneau TM.
    N Engl J Med; 1997 Apr 24; 336(17):1202-7. PubMed ID: 9110907
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Peripheral neuropathy in osteosclerotic myeloma: clinical and electrodiagnostic improvement with chemotherapy.
    Donofrio PD, Albers JW, Greenberg HS, Mitchell BS.
    Muscle Nerve; 1984 Feb 24; 7(2):137-41. PubMed ID: 6325905
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Prognosis and therapy of multiple myeloma].
    Sonntag RW.
    Schweiz Med Wochenschr; 1978 Aug 12; 108(32):1247-51. PubMed ID: 675217
    [Abstract] [Full Text] [Related]

  • 18. Clinical images: Skeletal muscle pseudo-hypertrophy in myeloma-associated amyloidosis.
    Lawson TM, Bevan MA, Williams BD.
    Arthritis Rheum; 2002 Aug 12; 46(8):2251. PubMed ID: 12209535
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.